Literature DB >> 3036826

Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes.

G Andersson, D Larhammar, E Widmark, B Servenius, P A Peterson, L Rask.   

Abstract

The genes of the polymorphic HLA-DR molecules are located within the human major histocompatibility complex. We have studied the HLA-DR genes of an HLA homozygous individual typed to be DR4, Dw4, and DRw53. Fourteen cosmid and phage clones from genomic libraries were isolated and grouped into three clusters comprising a total of 165 kilobases. These clusters contain four DR beta genes. Nucleotide sequence determination showed that two of the genes encode beta chains that carry the DR4 and DRw53 specificities, respectively, while the other two genes are presumably pseudogenes. Comparisons of the nucleotide sequences of all four DR beta genes of the DR4 haplotype show that the genes are extensively similar, approximately 90% in both exons and introns. All four genes are equally similar to each other. These observations are consistent with the notion that the genes arose by duplications that were followed by homogenization through gene conversion. The existence of more than one DR beta gene homologue but only a single DR alpha gene homologue in mouse, rabbit, and cattle suggests that the DR beta gene duplications occurred at or early during mammalian speciation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

2.  Expression of alternatively spliced HLA class II transcripts in lymphoid and nonlymphoid tissues.

Authors:  C Seidl; J S Lee
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  DRw52-group haplotypes are frequent acceptors of DRw15-Dw2 DQ genes in DQA1-DRB1 recombination.

Authors:  P Santamaria; H J Noreen; A L Lindstrom; J J Barbosa; A J Faras; M Segall; S S Rich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 5.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

6.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

7.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  Primate DRB genes from the DR3 and DR8 haplotypes contain ERV9 LTR elements at identical positions.

Authors:  A C Svensson; N Setterblad; S Sigurdardóttir; L Rask; G Andersson
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates.

Authors:  A W Dangel; A R Mendoza; B J Baker; C M Daniel; M C Carroll; L C Wu; C Y Yu
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Exon-intron organization of Xenopus MHC class II beta chain genes.

Authors:  F Kobari; K Sato; B P Shum; S Tochinai; M Katagiri; T Ishibashi; L Du Pasquier; M F Flajnik; M Kasahara
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.